Jyong Biotech Ltd. Ordinary Shares

NASDAQ:MENS

Biotechnology

Healthcare
$1.86 -1.41%

-$0.02 today

Market cap
$141.41M
Beta
2.08
P/E (TTM)
-25.1
EPS (TTM)
-$0.06
52W Low $1.43High $67.00

Volume 0.07M

Average 0.10M

Returns on capital

Jyong Biotech Ltd. Ordinary Shares management

Start with the returns management earns on the capital it controls, then review the people, their trades, and growth quality.

Return Metrics

ROE, ROIC & ROA over time

Management
Older years hidden. Sign in to unlock

ROE

18.8%

avg 15.0%

ROIC

46.0%

avg -56.1%

ROA

-22.5%

avg -43.1%

Analysis

ROIC is currently the strongest return metric at 46.0% versus its period average of -56.1%. 2 of 3 return metrics are above their quality threshold, which helps indicate how efficiently the company turns capital and assets into profit.

Leadership

Who runs the company?

Review the executive team, tenure, compensation, and ownership.

Management

Key executives, compensation & ownership

NameTitleCompensationAgeShares OwnedOwnership %

Fenglin Hsu

Chief Technology Officer & Director—77——

Fu-Feng Kuo

Chief Executive Officer & Chairwoman of the Board—68——

Wanwen Su

Chief Science Officer—51——

Wei Zhang

Chief Financial Officer—45——

Ownership uses each executive's latest SEC Form 4 holding only when the full name maps to one reporting CIK.

Insider trading

Are insiders buying or selling?

Follow recent insider purchases and sales reported on Form 4.

Insider Trading

SEC Form 4 transactions — last 12 months

No open-market purchases or sales in the last 12 months.

Growth analysis

Is management growing the business?

Compare historical growth with analyst forecasts across revenue, earnings, and cash flow.

Growth Analysis

Historical CAGR & forward analyst estimates

Metric 10yr 5yr3yr Fwd Est.
EPSN/AN/AN/A
N/A —
RevenueN/AN/AN/A
N/A —
Net IncomeN/AN/AN/A
N/A —
EBITN/AN/AN/A
N/A —

Analysis

Analysis will appear once historical growth or forward estimates are available for this company.

Competitors

Who does Jyong Biotech Ltd. Ordinary Shares compete with?

Open similar companies to compare how their management teams allocate capital.

Questions

Management questions

Common questions about MENS's management, answered from reported figures.

Who manages MENS?

Jyong Biotech Ltd. Ordinary Shares (MENS) lists 4 active executives. The top listed executive is Fenglin Hsu, Chief Technology Officer & Director.